Journal of Cancer Medicine & Metastasis (DOI prefix: 10.46619) (Impact Factor: 3.32) is an International open access, peer-reviewed journal which is renamed Title of "Cancer Medicine Journal".
It will be continued with this new name "Journal of Cancer Medicine and Metastasis". It covers all areas of cancer research, especially novel concepts and theories, new methods/techniques, new therapeutic agents, and alternative approaches for early detection and intervention of cancer which will be get published from Volume 6.
Journal of Cancer Medicine & Metastasisfocuses to entrench the field of cancer or oncology by publishing articles focused upon disease management, hinderance/prevent, methods for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. Journal provides platform for rapid publication of high quality results in cancer research while maintaining rigorous single blinded peer-review process.
At this stage, the submission and publication of manuscripts is at discount for all students/emeritus professor. The published articles are made freely available to online readers.
Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC https://www.coronavirus.gov
Get the latest research https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Kenjiro Nagai, Syo Nagai, Yuji Okubo and Keisuke Teshigawara
Ajit Kumar Saxena
Main aim of the journal is to improve and share knowledge & global health outcomes by publishing Research article, Review, Case reports to convey important practice messages and best research should be published and made widely accessible as quickly as possible in scientific community. Journal of Cancer Medicine & Metastasis welcome all kind of articles covering areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and other related fields.
The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: